Clinical trial
The Relative Effects of Olmesartan Medoxomil, Irbesartan and Valsartan on the…
NCT00185055 · Daiichi Sankyo, Industry · Completed
Key facts
| NCT number | NCT00185055 |
|---|---|
| Title | The Relative Effects of Olmesartan Medoxomil, Irbesartan and Valsartan on the Activity of the Blood Pressure Control System in Healthy Subjects |
| Official title | The Relative Effects of Single Doses of Olmesartan Medoxomil, Irbesartan and Valsartan at High Dosage Levels on the Renin-Angiotensin-Aldosterone System in Healthy Normal Subjects |
| Lead sponsor | Daiichi Sankyo, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | Olmesartan medoxomil, Irbesartan, Valsartan |
| Enrollment | 20 |
| Start date | Nov 1, 2004 |
| Completion | Feb 1, 2005 |
| First posted | Sep 16, 2005 |
| Last update posted | Sep 16, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: